Colgate-Palmolive Company $CL Holdings Trimmed by ABN AMRO Bank N.V.

ABN AMRO Bank N.V. reduced its position in shares of Colgate-Palmolive Company (NYSE:CL) by 29.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 39,750 shares of the company’s stock after selling 16,549 shares during the period. ABN AMRO Bank N.V.’s holdings in Colgate-Palmolive were worth $3,133,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Maseco LLP acquired a new position in shares of Colgate-Palmolive in the 4th quarter worth approximately $27,000. Copia Wealth Management bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth approximately $29,000. Cloud Capital Management LLC acquired a new stake in Colgate-Palmolive during the third quarter valued at approximately $30,000. Global Wealth Strategies & Associates boosted its holdings in Colgate-Palmolive by 300.0% during the fourth quarter. Global Wealth Strategies & Associates now owns 400 shares of the company’s stock worth $32,000 after buying an additional 300 shares in the last quarter. Finally, Camelot Portfolios LLC bought a new stake in Colgate-Palmolive during the fourth quarter worth approximately $32,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CL has been the topic of several research reports. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $102.00 price target on shares of Colgate-Palmolive in a report on Monday, May 4th. Bank of America reduced their price objective on Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating for the company in a research note on Friday, April 10th. Weiss Ratings upgraded Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Evercore upped their target price on Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, February 2nd. Finally, Morgan Stanley reiterated an “overweight” rating on shares of Colgate-Palmolive in a research report on Monday, May 4th. Twelve research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $95.88.

Insider Buying and Selling at Colgate-Palmolive

In other news, COO Panagiotis Tsourapas sold 35,000 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $94.61, for a total value of $3,311,350.00. Following the completion of the sale, the chief operating officer directly owned 10,415 shares of the company’s stock, valued at $985,363.15. This represents a 77.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.43% of the stock is owned by corporate insiders.

Colgate-Palmolive Price Performance

CL opened at $86.68 on Tuesday. The firm has a market capitalization of $69.54 billion, a P/E ratio of 33.73, a PEG ratio of 4.54 and a beta of 0.31. The stock has a fifty day moving average of $86.98 and a 200-day moving average of $84.46. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.03. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.Colgate-Palmolive’s revenue for the quarter was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.91 earnings per share. Equities analysts forecast that Colgate-Palmolive Company will post 3.83 EPS for the current fiscal year.

Colgate-Palmolive Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Monday, April 20th will be paid a dividend of $0.53 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 82.49%.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.